elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q51017942-3E6C29AA-5B92-4B15-98BB-BD66017866F9
Q51017942-3E6C29AA-5B92-4B15-98BB-BD66017866F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51017942-3E6C29AA-5B92-4B15-98BB-BD66017866F9
Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates.
P2860
Q51017942-3E6C29AA-5B92-4B15-98BB-BD66017866F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51017942-3E6C29AA-5B92-4B15-98BB-BD66017866F9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b038df76b6ab96a5f8bc5095e4e16cde5950d904
P2860
Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.